Pharmaceuticals News and Research

RSS

Imaxio receives FP7 grant to support the development of S. aureus vaccine

Imaxio, a biopharmaceutical company specialized in vaccines, together with its partners from the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems, is pleased to announce today a European Union award of EUR 5.5 million to support the ‘Bellerophon Project’ consortium to develop a vaccine against Staphylococcus aureus (S. aureus).

3 Jul 2013

Sartorius launches new Sartocheck 4 plus Bag tester

Sartorius Stedim Biotech (SSB), a leading international equipment supplier for the pharma and biotech industries, has launched the new Sartocheck 4 plus Bag tester, the latest addition to its well-established Sartocheck line.

From Sartorius 3 Jul 2013

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Germany since December 2012 for men with metastatic prostate cancer that is not responsive to hormone blockade, who only have mild symptoms or so far none at all, and in whom chemotherapy is not yet indicated.

3 Jul 2013

West Pharmaceutical Services expands NovaGuard portfolio of needle safety products

West Pharmaceutical Services, Inc., a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products.

2 Jul 2013

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of hemophilia and rare bleeding disorders.

2 Jul 2013

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.

2 Jul 2013

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus.

2 Jul 2013

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.

2 Jul 2013

Idera Pharmaceuticals reports Phase 1 clinical trial results of IMO-8400

Idera Pharmaceuticals, Inc. announced results of a Phase 1 clinical trial of IMO-8400, a first-in-class antagonist of Toll-like Receptors 7, 8, and 9 being developed for potential applications in autoimmune and inflammatory diseases.

2 Jul 2013

NPC and George Washington SPHHS selects recipient of two-year fellowship in CER policy

The National Pharmaceutical Council (NPC) and the George Washington University School of Public Health and Health Services (SPHHS) today announced the selection of Chuck Shih, Ph.D., as the recipient of a new two-year fellowship in comparative effectiveness research (CER) policy.

2 Jul 2013

Teva signs agreement with Verinata Health for commercialization of verifi prenatal test in Israel

Illumina, Inc. today announced that Teva Pharmaceutical Industries Ltd. signed an exclusive agreement with Verinata Health, an Illumina company, for the commercialization of the verifi non-invasive prenatal test in Israel.

1 Jul 2013

Researchers find new treatment option for schizophrenia

A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier to affect the histamine system in the brain.

1 Jul 2013

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization to the European Medicines Agency for the oral multi-kinase inhibitor Nexavar (sorafenib) tablets for the treatment of locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer.

1 Jul 2013

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

The World Health Organization's new HIV treatment guidelines, released today at the 2013 International AIDS Society Conference, include new antiretroviral therapy recommendations for HIV-infected children, and will mean that more children will be on better treatments.

1 Jul 2013

First clinical study for development of SGX203 to treat pediatric Crohn's disease

Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.

1 Jul 2013

Biomolecular interactions of nanoparticles can improve drug development, optical sensors and more

In chemical reactions, left and right can make a big difference. A "left-handed" molecule of a particular chemical composition could be an effective drug, while its mirror-image "right-handed" counterpart could be completely inactive.

30 Jun 2013

TSRI professor receives $3.75M "mega-grants" from Russian government

Valery Fokin, professor in the Department of Chemistry at The Scripps Research Institute (TSRI), has been awarded a prestigious grant from the Russian government for $3.75 million over three years, with the possibility of a two-year renewal.

28 Jun 2013

Study shows "bioadhesive" coating can increase intestinal uptake of protein-based drugs

For protein-based drugs such as insulin to be taken orally rather than injected, bioengineers need to find a way to shuttle them safely through the stomach to the small intestine where they can be absorbed and distributed by the bloodstream.

28 Jun 2013

RUCDR Infinite Biologics receives $44.5 million Cooperative Agreement award from NIMH centre

RUCDR Infinite Biologics, the world's largest university-based biorepository, received a $44.5 million Cooperative Agreement award from the National Institute of Mental Health earlier this month to support its NIMH Center for Collaborative Genomics Research on Mental Disorders, which provides services to NIMH-funded scientists engaged in genomic research on mental disorders.

28 Jun 2013

Parkland Health Mart Pharmacy honored with McKesson's Pharmacy of the Year award

McKesson Corporation announced that its 2013 Pharmacy of the Year grand prize winner is Parkland Health Mart Pharmacy, located in Desloge, Missouri. Parkland Health Mart Pharmacy was honored in a special awards ceremony during the Opening General Session at the 2013 McKesson ideaShare conference.

28 Jun 2013

Pharmaceuticals News and Research

Imaxio receives FP7 grant to support the development of S. aureus vaccine

Sartorius launches new Sartocheck 4 plus Bag tester

Abiraterone can prolong overall survival and delay severe pain in prostate cancer patients

West Pharmaceutical Services expands NovaGuard portfolio of needle safety products

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Study shows that PCCs can reverse blood thinning effects of XARELTO in healthy subjects

Idera Pharmaceuticals reports Phase 1 clinical trial results of IMO-8400

NPC and George Washington SPHHS selects recipient of two-year fellowship in CER policy

Teva signs agreement with Verinata Health for commercialization of verifi prenatal test in Israel

Researchers find new treatment option for schizophrenia

Bayer, Onyx submit sNDA to FDA, marketing authorization application to EMA for Nexavar tablets

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

First clinical study for development of SGX203 to treat pediatric Crohn's disease

Biomolecular interactions of nanoparticles can improve drug development, optical sensors and more

TSRI professor receives $3.75M "mega-grants" from Russian government

Study shows "bioadhesive" coating can increase intestinal uptake of protein-based drugs

RUCDR Infinite Biologics receives $44.5 million Cooperative Agreement award from NIMH centre

Parkland Health Mart Pharmacy honored with McKesson's Pharmacy of the Year award

Event guide: World ADC London eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence